Monitoring phospholipase A2 activity with Gd-encapsulated phospholipid liposomes

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Cheng, Zhiliang ^a   Tsourkas, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-METHOXY-POLY(ETHYLENE GLYCOL 2000); ARACHIDONIC ACID DERIVATIVE; CONTRAST MEDIUM; DIPALMITOYLPHOSPHATIDYLCHOLINE; GADOLINIUM; GADOTERIDOL; HETEROCYCLIC COMPOUND; LIPOSOME; MACROGOL DERIVATIVE; METHYL ARACHIDONYLFLUOROPHOSPHONATE; ORGANOMETALLIC COMPOUND; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; PHOSPHONIC ACID DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG FORMULATION; DRUG RELEASE; ELAPIDAE; ISOLATION AND PURIFICATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY; PROCEDURES;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; ARACHIDONIC ACIDS; CONTRAST MEDIA; DRUG COMPOUNDING; DRUG LIBERATION; ELAPIDAE; GADOLINIUM; HETEROCYCLIC COMPOUNDS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHONATES; PERMEABILITY; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASES A2; POLYETHYLENE GLYCOLS;

EID: 84923306398     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06958     Document Type: Article

References (22)

1. Kugiyama, K. et al. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation 100, 1280-1284 (1999).
2. Agarwal, N. &Pitchumoni, C. S. Assessment of severity in acute pancreatitis. AmJ Gastroenterol 86, 1385-1391 (1991).
3. Green, J. A. et al. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 15, 355-367 (1991).
4. Abe, T. et al. Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer. Int J Cancer 74, 245-250 (1997).
5. Mirsky, V. M., Mass, M., Krause, C. & Wolfbeis, O. S. Capacitive Approach To Determine Phospholipase A(2) Activity toward Artificial and Natural Substrates. Anal Chem 70, 3674-3678 (1998).
6. Aili, D., Mager, M., Roche, D. & Stevens, M. M. Hybrid nanoparticle-liposome detection of phospholipase activity. Nano Lett 11, 1401-1405 (2011).
7. Rose, T. M. & Prestwich, G. D. Fluorogenic phospholipids as head group-selective reporters of phospholipase A activity. ACS Chem Biol 1, 83-91 (2006).
8. Chemburu, S. et al. Conjugated polyelectrolyte supported bead based assays for phospholipase A2 activity. J Phys Chem B 112, 14492-14499 (2008).
9. Cosentino, M. J. & Ellis, L. C. A rapid simple radiometric assay for phospholipase A2 activity. Prostaglandins 22, 309-322 (1981).
10. Aufenanger, J., Zimmer, W. & Kattermann, R. Characteristics and clinical application of a radiometric Escherichia coli-based phospholipase A2 assay modified for serum analysis. Clin Chem 39, 605-613 (1993).
11. Nwe, K., Huang, C. H. & Tsourkas, A. Gd-labeled glycol chitosan as a pHresponsive magnetic resonance imaging agent for detecting acidic tumor microenvironments. J Med Chem 56, 7862-7869 (2013).
12. Zhang, S., Wu, K. & Sherry, A. D. A Novel pH-Sensitive MRI Contrast Agent. Angew Chem Int Ed Engl 38, 3192-3194 (1999).
13. Tu, C. Q., Osborne, E. A. & Louie, A. Y. Synthesis and characterization of a redoxand light-sensitive MRI contrast agent. Tetrahedron 65, 1241-1246 (2009).
14. Dhingra, K. et al. Towards extracellular Ca21 sensing by MRI: synthesis and calcium-dependent 1H and 17O relaxation studies of two novel bismacrocyclic Gd31 complexes. J Biol Inorg Chem 13, 35-46 (2008).
15. Berkovic, G., Krongauz, V. & Weiss, V. Spiropyrans and spirooxazines for memories and switches. Chem Rev 100, 1741-1753 (2000).
16. Louie, A. Y. et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18, 321-325 (2000).
17. Moats, R. A., Fraser, S. E. & Meade, T. J. A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew Chem Int Edit 36, 726-728 (1997).
18. Cheng, Z. & Tsourkas, A. Paramagnetic porous polymersomes. Langmuir 24, 8169-8173 (2008).
19. Cheng, Z., Thorek, D. L. & Tsourkas, A. Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents. Adv Funct Mater 19, 3753-3759 (2009).
20. Raghupathi, R. & Franson, R. C. Inhibition of phospholipase A2 by cisunsaturated fatty acids: evidence for the binding of fatty acid to enzyme. Biochimica et biophysica acta 1126, 206-214 (1992).
21. Farber, S. A., Olson, E. S., Clark, J. D. &Halpern, M. E. Characterization of Ca21-dependent phospholipase A2 activity during zebrafish embryogenesis. J Biol Chem 274, 19338-19346 (1999).
22. Charniot, J. C. et al. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Int J Cardiol 168, 132-138 (2013).